Hemodialysis
Conditions
Interventions
Treatment group:Implanting bio-artificial blood vessels
Control group:Implanting PTFE artificial vascular graft
Sponsors
Third Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who need implanting the peripheral arteriovenous graft, age 18-70 years old, and life expectancy greater than two years, can communicate with researchers, can understand the relevant content of the clinical trials, to obey the research plan, can provide the writing signed and dated informed consent.
Exclusion criteria
Exclusion criteria: Patients who are suffering from a serious heart disease or medical history, symptoms of myocardial infarction or stroke 6 months before the clinical trials, or ventricular need continuous treatment of tachycardia, or unstable angina, or a pacemaker; Patients who are suffering from severe peripheral vascular disease or related history, or skin disease around surgery position or skin infectious lesions or other artificial vascular grafts have been implanted, or limb proximal vein or central vein stenosis, thrombosis, or other adjacent disease blocking venous return, or plan to renal transplantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The cumulative patency rate (360 days after transplantation); | — |
Secondary
| Measure | Time frame |
|---|---|
| Phase I patency rate (180 days or 360 days after transplantation);Phase II patency rate (180 days or 360 days after transplantation);Failure rate;Compression hemostasia time after puncture; | — |
Countries
China
Contacts
Public ContactZhu Chuhong
Outcome results
None listed